Genflow to attend JP Morgan Healthcare Conference

Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF) will attend the JP Morgan Healthcare Conference in San Francisco on 12–15 January, a key global meeting point for healthcare investors and industry leaders. The company develops gene therapies targeting the SIRT6 longevity pathway and said the event offers a chance to meet prospective partners and pharmaceutical groups as it advances its lipid nanoparticle delivery work for mRNA-based treatments. Chief executive Eric Leire said the meetings planned for the conference reflect growing interest in technologies aimed at extending healthy lifespan.